EC
PTGX icon

EcoR1 Capital’s Protagonist Therapeutics PTGX Stock Holding History

EcoR1 Capital’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-381,711
Closed -$9.04M – 92
2022
Q1 		$9.04M Sell
381,711
-2,257,995
-86% -$63.6M 0.28% 43
2021
Q4 		$90.3M Buy
2,639,706
+1,195,906
+83% +$37.8M 2.88% 10
2021
Q3 		$25.6M Buy
+1,443,800
New +$61.6M 0.9% 21
2018
Q2 		– Sell
-1,083,567
Closed -$9.31M – 40
2018
Q1 		$9.31M Buy
+1,083,567
New +$20.4M 1% 24

Other funds holding PTGX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return